VIHC Vaccine Injury Help Center Posted on June 6, 2011 by Vaccine Injury Lawyer According to an article for Medical News Today, “The immune response against the virus that causes cervical cancer is stronger and sustained following vaccination with GlaxoSmithKline’s (GSK) candidate HPV vaccine formulated with the innovative AS04 adjuvant compared to using the same […]
Aluminum Toxicity: A misdiagnosed epidemic (Part 1)
ProLiberty.com From the December 2007 Idaho Observer: By Ingri Cassel Aluminum is the third most abundant element (8 percent) in the Earth’s crust, exceeded by oxygen (47 percent) and silicon (28 percent). Because of its strong affinity to oxygen, aluminum never occurs as a metal in nature but is found only in the form of […]
Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants.
Eisenbarth SC, Colegio OR, O’Connor W, Sutterwala FS, Flavell RA. Source Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut 06520, USA. Abstract Aluminium adjuvants, typically referred to as ‘alum’, are the most commonly used adjuvants in human and animal vaccines worldwide, yet the mechanism underlying the stimulation of the immune system by […]
A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome
Christopher Exley, Louise Swarbrick, Rhomain K. Gherardi, and Francois-Jérôme Arthier Summary: Macrophagic myofasciitis and chronic fatigue syndrome are severely disabling conditions which may be caused by adverse reactions to aluminium-containing adjuvants in vaccines. While a little is known of disease aetiology both conditions are characterised by an aberrant immune response, have a number of prominent […]
The immunobiology of aluminium adjuvants: how do they really work?
Christopher Exley, Peter Siesjö, and Håkan Eriksson ABSTRACT: Aluminium adjuvants potentiate the immune response, thereby ensuring the potency and efficacy of typically sparingly available antigen. Their concomitant critical mportance in mass vaccination programmes may have prompted recent intense interest in understanding how they work and their safety. Progress in these areas is stymied, however, by […]